Journal of Advances in Developmental Research
E-ISSN: 0976-4844
•
Impact Factor: 9.71
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 17 Issue 1
2026
Indexing Partners
Docking study of ellagic acid against SARS COv2 protins
| Author(s) | Pranali Prakash Borse, Syeda Afifa |
|---|---|
| Country | India |
| Abstract | The global outbreak of COVID-19 caused by the SARS-CoV-2 created an urgent need for effective antiviral agents with improved safety and therapeutic efficacy. In recent years, Computer-Aided Drug Design (CADD) and molecular docking techniques have emerged as important tools in modern drug discovery because they provide rapid, economical, and reliable screening of potential drug candidates. The present study was undertaken to evaluate the antiviral potential of Ellagic Acid, a naturally occurring polyphenolic compound found in pomegranate, berries, and walnuts, against important SARS-CoV-2 proteins through molecular docking analysis. Ellagic acid is known for its antioxidant, anti-inflammatory, and antiviral properties, making it a promising natural therapeutic candidate. In this study, major SARS-CoV-2 target proteins involved in viral replication and infection were selected, including: • Main Protease (Mpro) • Spike Glycoprotein • RNA-Dependent RNA Polymerase (RdRp) The three-dimensional crystal structures of the selected proteins were retrieved from the Protein Data Bank (PDB) database, while the chemical structure of ellagic acid was obtained from the PubChem Database. Protein and ligand preparation were carried out using standard molecular modeling procedures prior to docking studies. Molecular docking analysis was performed using: |
| Keywords | - |
| Field | Medical / Pharmacy |
| Published In | Volume 17, Issue 1, January-June 2026 |
| Published On | 2026-05-25 |
| DOI | https://doi.org/10.71097/IJAIDR.v17.i1.1958 |
| Short DOI | https://doi.org/hb5m8c |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJAIDR DOI prefix is
10.71097/IJAIDR
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.